Plenary 1

Plenary 2

Plenary 3

Plenary 4
The year inThe year in neuroendocrinology Basic
The year inThe year in neuroendocrinology Clinical


Symposium 1EYRC - Advances in hypopituitarismThe Molecular Basis of Congenital Hypopituitarism
Dysregulated peptide amidation as a new cause of hypopituitarism
Human iPS cells as model for congenital hypopituitarism
Symposium 2Beyond the hotspotImprinting in hypothalamus-pituitary pathology
Non-coding RNAs: mere messengers or causative factors?
Pituitary tumor microenvironment 
Symposium 3Circadian neuroendocrinologySleep & energy balance
Circadian clock and insulin resistance
Pacing the glucocorticoids 
Symposium 4Mechanisms behind the long term cortisol effectsCell- and tissue specificity of gluocorticoids actions.
Long-term consequences of hypercortisolism
Epigenetic modulation by glucocorticoids
Short presentation: Bone consequences of chronic hypercortisolism
Symposium 5New on NeurohypophysisOxytocin beyond delivery
New diagnostic tests in diabetes insipidus
Management of hyponatermia in different clinical scenarios
Symposium 6Neuroendocrine homeostasisSynaptic communication & reproductive circuits 
Stem cell-derived paracrine signals in pituitary homeostasis
The pituitary stalk - inflamantory, imaging, clinical interpratation
Symposium 7AcromegalyPrecision medicine in the treatment of acromegaly
Paradoxical GH increase during OGTT & its implications in managing acromegaly
Short presentation: Klotho, a new tool in acromegaly diagnostics 
Acromegaly in the elderly patients
Short presentation: FTO polymorphisms & cardiovascular comorbidities
Symposium 8Understanding neuroendocrinology through scRNAseq Molecular determinants of hypothalamic development
Pleiotropic effects of SOX2 in pituitary stem and tumour cells
Symposium 9Aggressive & difficultEmerging pharmacological therapies for craniopharyngiomas
Craniopharyngioma: relapse
Surgical indications and limitation for recurrent pituitary tumors
Update on temozolomide: results of a European Society of Endocrinology (ESE) survey 
What is the role of pathology??
Short presentation: Immunotherapy for aggressive pituitary tumours & carcinomas

MTE & Scientific

Clinical 1Diagnostic advancesNew biochemical tools in the diagnosis and follow up of Cushing's disease
Clinical 2Meet-the-expertPituitary tumours in pregnancy 
Clinical 3Meet-the-expertRare sellar tumors: Posterior pituitary cell tumors/chordoma/sellar meningioma
Clinical 4Meet-the-expertCushing's syndrome due to ectopic ACTH secretion
Clinical 5Meet-the-expertHow to manage recurrent non-functioning pitnets
Clinical 6Meet-the-expertTesting the recovery of the axis in tertiary adrenal insufficiency
Clinical 7Meet-the-expertHyponatremia
Clinical 8Meet-the-expertHormone receptor targets in neuroendocrine tumours
Basic 1Scientific highlightPOMC neuronal heterogeneity in energy balance and beyond
Basic 2Technical advanceProbing genome‚Äôs architecture in cell plasticity and disease 
Basic 3Technology to watch Spatially resolved transcriptomics
Basic 4Technology to watch Intraoperative RAMAN spectroscopy 


ENEA-relatedENEA studiesReport from the ENEA multicenter study on hyperprolactinemia

From the ENEA endorsing groups: European Pituitary Pathology Group (EPPG) EPPG updates in pituitary tumour pathology 
ENDO-ERNMeet the ENDO-ERNHow can ERN help my praxis?

Evening events

EYRC Poster Party